{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:57Z","timestamp":1791182037649,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T00:00:00Z","timestamp":1188259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> Mast cells (MCs) play a key role in allergic diseases through the release of inflammatory mediators, which are responsible of allergic symptoms. Mastocytosis is characterized by an abnormal proliferation and accumulation of mast cells, in which mediators are released intermittingly or continuously. Despite these clinical similarities, few studies have addressed the presence of allergic symptoms in mastocytosis patients, including anaphylaxis.<\/jats:p><jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> A prospective evaluation was carried out to study the prevalence of allergic diseases in patients with mastocytosis and their impact on the natural history of mastocytosis.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> A questionnaire was given to 210 patients with mastocytosis to evaluate the history of asthma, rhinitis, conjunctivitis, atopic dermatitis, urticaria and anaphylaxis. Patients underwent total IgE, Phadiatop<jats:sup>\u00ae<\/jats:sup> infant (aeroallergens and food allergens), specific IgE to latex and to <jats:italic>Anisakis simplex<\/jats:italic> determinations. Skin tests were done to 72 patients.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> The prevalence of allergy, as defined by clinical symptoms associated to specific IgE, was 23.9%. Total IgE level was significantly higher in patients with allergy as compared with patients without allergy (median 58 vs. 16.5\u2003kU\/L, <jats:italic>P<\/jats:italic>&lt;0.0001). Anaphylactic symptoms were present in 36 patients (22%), in nine the allergen was identified. Males had more allergy and anaphylactic symptoms than females (61.5% vs. 38.5% and 72% vs. 28%, respectively).<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> Allergic diseases coexist in patients with mastocytosis with similar frequency as compared with the general population. Anaphylactic symptoms are more prevalent in males with mastocytosis and in patients with elevated IgE.<\/jats:p><jats:p><jats:bold>Capsule summary\n\t\t\t\t\t<\/jats:bold> The prevalence of allergy in mastocytosis is similar to the general population. Anaphylactic symptoms are more prevalent in males and in patients with elevated IgE. The coexistence of atopy does not influence mastocytosis\u2010associated symptoms.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2007.02804.x","type":"journal-article","created":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T04:11:21Z","timestamp":1188619881000},"page":"1547-1555","source":"Crossref","is-referenced-by-count":210,"title":["Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)"],"prefix":"10.1111","volume":"37","author":[{"given":"D.","family":"Gonz\u00e1lez de Olano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"De La Hoz Caballer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"N\u00fa\u00f1ez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"S\u00e1nchez Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cuevas Agust\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Di\u00e9guez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"\u00c1lvarez Twose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Escribano Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(89)90272-7"},{"key":"e_1_2_6_3_2","first-page":"3710","article-title":"Slow reacting substances of anaphylaxis","volume":"77","author":"Lewis RA","year":"1980","journal-title":"identification of leukotrienes C-1 and D from human and rat sources"},{"key":"e_1_2_6_4_2","first-page":"508","article-title":"Assessment of the extent of cutaneous involvement in children and adults with mastocytosis","volume":"48","author":"Brockow K","year":"2003","journal-title":"relationship to symptomatology, tryptase levels, and bone marrow pathology"},{"key":"e_1_2_6_5_2","first-page":"597","article-title":"Mastocytosis and atopy","volume":"45","author":"Muller U","year":"1990","journal-title":"a study of 33 patients with urticaria pigmentosa"},{"key":"e_1_2_6_6_2","first-page":"529","article-title":"Morphologic properties of neoplastic mast cells","volume":"25","author":"Sperr W","year":"2001","journal-title":"delineation of stages of maturation and implication for cytological grading of mastocytosis"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199809000-00013"},{"key":"e_1_2_6_8_2","first-page":"543","article-title":"Diagnosis of mastocytosis","volume":"25","author":"Horny HP","year":"2001","journal-title":"general histopathological aspects, morphological criteria, and immunohistochemical findings"},{"key":"e_1_2_6_9_2","first-page":"2731","article-title":"Indolent systemic mast cell disease in adults","volume":"91","author":"Escribano L","year":"1998","journal-title":"immunophenotypic characterization of bone marrow mast cells and its diagnostic implications"},{"key":"e_1_2_6_10_2","first-page":"1","article-title":"Immunophenotypic analysis of mast cells in mastocytosis","volume":"58","author":"Escribano L","year":"2004","journal-title":"when and how to do it. Proposals of the Spanish network on mastocytosis (REMA)"},{"key":"e_1_2_6_11_2","first-page":"677","article-title":"One\u2010step detection of c\u2010kit point mutations using PNA\u2010mediated PCR\u2010clamping and hybridization probes","volume":"81","author":"Sotlar K","year":"2002","journal-title":"Am J Pathol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015545"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2001.790108.x"},{"key":"e_1_2_6_14_2","first-page":"603","article-title":"Diagnostic criteria and classification of mastocytosis","volume":"25","author":"Valent P","year":"2001","journal-title":"a consensus proposal"},{"key":"e_1_2_6_15_2","first-page":"832","article-title":"Revised nomenclature for allergy for global use","volume":"113","author":"Johansson SG","year":"2004","journal-title":"report of the nomenclature review committee of the world allergy organization, October 2003"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2001.00002.x-i1"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00130832-200208000-00008"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14b09.x"},{"issue":"2","key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic\u2010dermatitis","volume":"92","author":"Hanifin JM","year":"1980","journal-title":"Acta Derm Venereol (Stockholm)"},{"key":"e_1_2_6_20_2","unstructured":"GINA Workshop Report. Global strategy of asthma management and prevention \u2013 updated April 2002 (Scientific information and recommendations for asthma programs. NIH Publication No. 02\u20103659). 2002."},{"issue":"14","key":"e_1_2_6_21_2","first-page":"48","article-title":"The European Academy of Allergology and Clinical Immunology","volume":"48","author":"Position paper: Allergen standardization and skin tests","year":"1993","journal-title":"Allergy"},{"key":"e_1_2_6_22_2","unstructured":"RabassaAB.Epidemiolog\u00eda de las alergias. In:Gabinete estudios socil\u00f3gicos Bernard Krief UCB Pharma SEAIC eds. La alergia en la pr\u00e1ctica cl\u00ednica diaria del M\u00e9dico de Asistencia Primaria y en la Farmacia. Patolog\u00edas al\u00e9rgicas de mayor alcance social.Programa Zyrterigon\u2010Data 2000. Madrid:Impressi\u00f3 S.A. 1999:25\u201337."},{"key":"e_1_2_6_23_2","first-page":"68","article-title":"Prevalencia de alergia en la poblaci\u00f3n adulta espa\u00f1ola","volume":"19","author":"Gaig P","year":"2004","journal-title":"Allergol Inmunol Clin"},{"key":"e_1_2_6_24_2","first-page":"761","article-title":"European study on asthma. Prevalence of bronchial hyperreactivity and asthma in young adults from 5 Spanish areas. Spanish 5 group of the European study on asthma","volume":"106","author":"Cort\u00e9s X","year":"1996","journal-title":"Med Clin (Barcelona)"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62964-X"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.7.2012143"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00013904"},{"key":"e_1_2_6_28_2","first-page":"55","volume-title":"Alergol\u00f3gica. Factores epidemiol\u00f3gicos, cl\u00ednicos y socioecon\u00f3micos de las enfermedades al\u00e9rgicas en Espa\u00f1a","author":"Sastre J","year":"1992"},{"key":"e_1_2_6_29_2","first-page":"255","volume-title":"Alergol\u00f3gica 2005. Factores epidemiol\u00f3gicos, cl\u00ednicos y socioecon\u00f3micos de las enfermedades al\u00e9rgicas en Espa\u00f1a en 2005","author":"Gamboa Seti\u00e9n PM.","year":"2006"},{"key":"e_1_2_6_30_2","first-page":"20","article-title":"Anisakis simplex","volume":"18","author":"Audicana MT","year":"2002","journal-title":"dangerous-dead and alive?"},{"key":"e_1_2_6_31_2","first-page":"337","article-title":"Prevalencia de la sensibilizaci\u00f3n a Anisakis simplex en tres \u00e1reas espa\u00f1olas en relaci\u00f3n a las diferentes tasas de consumo de pescado. Relevancia de la alergia a Anisakis simplex. Estudio multic\u00e9ntrico de SEAIC","volume":"16","author":"Fern\u00e1ndez de Corres L","year":"2001","journal-title":"Allergol Inmunol Clin"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1998.tb04097.x"},{"key":"e_1_2_6_33_2","first-page":"1033","article-title":"Anaphylaxis","volume":"33","author":"Mullins RJ.","year":"2003","journal-title":"risk factors for recurrence"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.11.033"},{"key":"e_1_2_6_35_2","first-page":"443","article-title":"Epidemiology of life\u2010threatening and lethal anaphylaxis","volume":"60","author":"Moneret\u2010Vautrin DA","year":"2005","journal-title":"a review"},{"key":"e_1_2_6_36_2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archinte.164.3.317","article-title":"A population\u2010based study of the incidence, cause and severity of anaphylaxis in the United Kingdom","volume":"164","author":"Peng MM","year":"2004","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.4.1693"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270925"},{"key":"e_1_2_6_39_2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0021-9258(18)54061-8","article-title":"Intracellular degradation of Fc gamma RIII in mouse bone marrow culture\u2010derived progenitor mast cells prevents its surface expression and associated function","volume":"268","author":"Lobell RB","year":"1993","journal-title":"J Biol Chem"},{"key":"e_1_2_6_40_2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4049\/jimmunol.152.2.811","article-title":"FcgammaR\u2010mediated endocytosis and expression of cell surface FcgammaRIIb1 and FcgammaRIIb2 by mouse bone marrow culture\u2010derived progenitor mast cells","volume":"152","author":"Lobell RB","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(02)00077-9"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04055.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(03)80711-X"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000083954"},{"key":"e_1_2_6_45_2","first-page":"158","article-title":"Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis","volume":"142","author":"Sonneck K","year":"2006","journal-title":"monoclonal mast cell activation syndrome"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2007.02804.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2007.02804.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:57:51Z","timestamp":1697234271000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2007.02804.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,28]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1365-2222.2007.02804.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2007.02804.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,28]]}}}